Shares of Vascular Solutions Inc. (NASDAQ:VASC) have earned an average recommendation of “Buy” from the six research firms that are presently covering the stock. One research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $51.80.

VASC has been the subject of several research reports. Needham & Company LLC reaffirmed a “buy” rating and issued a $58.00 price target on shares of Vascular Solutions in a research report on Wednesday, October 26th. Zacks Investment Research raised shares of Vascular Solutions from a “hold” rating to a “buy” rating and set a $52.00 price target for the company in a research report on Thursday, July 28th. Canaccord Genuity set a $53.00 price target on shares of Vascular Solutions and gave the stock a “buy” rating in a research report on Tuesday, October 25th. Piper Jaffray Cos. upped their price target on shares of Vascular Solutions from $45.00 to $49.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 26th. Finally, TheStreet raised shares of Vascular Solutions from a “hold” rating to a “buy” rating in a research report on Monday, July 25th.

A number of hedge funds and other institutional investors have recently modified their holdings of VASC. Falcon Point Capital LLC raised its position in shares of Vascular Solutions by 12.4% in the second quarter. Falcon Point Capital LLC now owns 42,579 shares of the medical device company’s stock worth $1,774,000 after buying an additional 4,710 shares during the last quarter. Capstone Asset Management Co. raised its position in shares of Vascular Solutions by 18.3% in the second quarter. Capstone Asset Management Co. now owns 9,580 shares of the medical device company’s stock worth $399,000 after buying an additional 1,480 shares during the last quarter. Emerald Acquisition Ltd. bought a new position in shares of Vascular Solutions during the second quarter worth about $4,836,000. Prudential Financial Inc. raised its position in shares of Vascular Solutions by 3.7% in the first quarter. Prudential Financial Inc. now owns 42,347 shares of the medical device company’s stock worth $1,378,000 after buying an additional 1,500 shares during the last quarter. Finally, Swiss National Bank raised its position in shares of Vascular Solutions by 2.5% in the second quarter. Swiss National Bank now owns 28,963 shares of the medical device company’s stock worth $1,207,000 after buying an additional 700 shares during the last quarter. Institutional investors and hedge funds own 83.25% of the company’s stock.

Shares of Vascular Solutions (NASDAQ:VASC) opened at 49.55 on Thursday. Vascular Solutions has a 52-week low of $24.34 and a 52-week high of $51.05. The company has a market cap of $868.76 million, a P/E ratio of 72.02 and a beta of 0.87. The firm has a 50-day moving average of $47.05 and a 200-day moving average of $44.02.

Vascular Solutions (NASDAQ:VASC) last announced its quarterly earnings results on Monday, October 24th. The medical device company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.01. Vascular Solutions had a net margin of 7.57% and a return on equity of 16.14%. The firm earned $41.80 million during the quarter. During the same period in the previous year, the company posted $0.27 EPS. Vascular Solutions’s revenue for the quarter was up 13.1% on a year-over-year basis. Equities research analysts forecast that Vascular Solutions will post $1.24 earnings per share for the current year.

About Vascular Solutions

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

5 Day Chart for NASDAQ:VASC

Receive News & Stock Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related stocks with our FREE daily email newsletter.